Concurrent Technologies Reports Record H1 Revenue and Profit Despite FX Challenges
Concurrent Tech H1 revenue soars 27% to £21.3m, profit hits £2.4m despite FX hit. Kratos launch & order book strength (AIM:CNC).
This article covers information on Concurrent Technologies PLC.
LON:CNCStrong First Half Performance Amid Currency Headwinds
Concurrent Technologies (AIM: CNC) just dropped a trading update that’s got investors leaning in. The embedded computing specialist posted record H1 revenue of £21.3 million – a solid 27% jump from last year’s £16.8 million. Even more impressively, profit before tax nudged up to £2.4 million (from £2.3 million) despite a £600,000 currency punch from unfavourable USD exchange rates. That’s like running uphill in a headwind and still setting a personal best.
Breaking Down the Numbers
- Revenue Surge: £21.3m (H1 2024: £16.8m) – driven by robust demand across products and systems.
- Profit Resilience: £2.4m PBT (H1 2024: £2.3m) – achieved despite FX shaving off £0.6m.
- Order Momentum: Intake hit £22.3m (H1 2024: £17.8m), signalling sustained demand.
- Design Wins: New strategic contracts secured, typically converting to orders in 2-3 years with 7-10 year lifespans.
Kratos: The Game-Changer in the Room
CEO Miles Adcock couldn’t hide his enthusiasm about the group’s new Kratos product – the only board in its class packing Intel’s industrial-grade Xeon 6 processor. Early customer reactions suggest it’s not just another widget. For a company specialising in harsh-environment tech, this innovation could cement their edge in defence and aerospace verticals. Adcock’s note that it’s “generating significant interest” feels like a quiet nod to future revenue streams.
Systems Business: From Investment to (Nearly) Break-Even
Remember that upfront investment in their Systems unit last year? It’s paying off. The division is mobilising effectively and nearing break-even – a crucial step toward diversifying beyond core product sales. With defence budgets globally under scrutiny, this operational efficiency matters.
Outlook: Confidence with a Side of Caution
The board reaffirmed full-year guidance (£43m revenue, £6m PBT), but Adcock’s commentary had two interesting layers:
- The Bullish: H2 has started well, design wins are stacking up, and Systems is transitioning from cost centre to contributor.
- The Pragmatic: That nod to “dependency on US defence contracts” and “potential headwinds from governmental reviews” is worth bookmarking. Supply chain snarls remain a watchpoint too.
The Bottom Line for Investors
Concurrent isn’t just weathering storms – it’s sailing through them. H1’s growth despite FX pain speaks to pricing power and operational discipline. The Kratos launch and Systems unit progression suggest long-term optionality beyond today’s numbers. Yes, US defence exposure warrants monitoring, but with a record order book and tech that’s clearly resonating? This feels like a company executing its playbook with quiet confidence. Keep an eye on those design wins – they’re the seeds of tomorrow’s revenue.
Related
Keep reading
Investing
Ten Technologies Preliminary Results 2026: Record EBITDA and Member Growth
Ten Technologies delivered record 2026 results as active members rose 23% and adjusted EBITDA increased 10% to £16.1 million.
JoshuaNovember 11, 2026
Investing
Winvia Entertainment completes The Online Giveaway Guys acquisition
Winvia Entertainment has completed its purchase of The Online Giveaway Guys' business and key assets, excluding liabilities, cash and receivables.
JoshuaNovember 10, 2026
Investing
RUA Life Sciences reaches positive adjusted EBITDA as Structural Heart spin-out reshapes the group
RUA Life Sciences expects £5.5 million revenue and £0.3 million adjusted EBITDA, but ABISS weakness and lower cash warrant attention.
JoshuaNovember 9, 2026
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.